Harmony Biosciences Holdings Inc

22 sept 2026, 19:45 UTC

Harmony Biosciences Holdings Inc shares fell sharply after an early gain, currently trading below Monday's close but above the 20-day moving average.

21 sept 2026, 21:10 UTC

Harmony Biosciences Holdings Inc is experiencing a significant decline in after-market trading, moving lower since Monday's close amid notable volatility.

18 sept 2026, 21:11 UTC

Harmony Biosciences Holdings Inc is experiencing a significant decline in after-market trading, moving lower from a minor peak shortly after Friday's close.

17 sept 2026, 23:16 UTC

Harmony Biosciences Holdings Inc saw a modest increase in after-market trading, positioned above its 20-day moving average and near its one-month range high.

16 sept 2026, 23:06 UTC

Harmony Biosciences' WAKIX® receives approval from Japan's Ministry of Health for treating excessive daytime sleepiness, contributing to a modest after-market gain.

15 sept 2026, 21:01 UTC

Harmony Biosciences Holdings Inc shares are trading higher in after-market hours, reflecting strong momentum despite no specific company news.

14 sept 2026, 20:08 UTC

Harmony Biosciences is higher during Monday's session, reflecting broader market gains since Friday. The stock pulled back from an earlier session high.

11 sept 2026, 22:56 UTC

Harmony Biosciences Holdings Inc is trading higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

9 sept 2026, 20:07 UTC

Harmony Biosciences Holdings Inc shares are lower during Wednesday's session, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

8 sept 2026, 20:13 UTC

Harmony Biosciences Holdings Inc is higher in after-market trading, supported by solid performance above its 20-day moving average and nearing its one-month trading range.

3 sept 2026, 20:02 UTC

Harmony Biosciences announced it will present EPX-100 data at a future congress. Shares are trading lower, reversing from an earlier session high.

2 sept 2026, 20:01 UTC

Harmony Biosciences Holdings Inc is higher today, reflecting positive market response despite no specific news. Broader market context includes slower job growth reported by ADP.

1 sept 2026, 23:01 UTC

Harmony Biosciences Holdings Inc shares are higher in after-market trading, continuing an upward trend from three consecutive sessions of gains. No specific news was identified.

31 ago 2026, 22:06 UTC

Harmony Biosciences shares are higher in after-market trading, rebounding from an initial dip amid geopolitical tensions affecting broader market conditions.

28 ago 2026, 20:07 UTC

Harmony Biosciences Holdings Inc shares are lower during Friday's session, continuing a decline since Thursday's close amid no specific news to explain the downturn.

27 ago 2026, 19:56 UTC

Harmony Biosciences will participate in the 2026 Cantor Global Healthcare Conference. Shares are higher today, reflecting positive market sentiment since Wednesday's close.

26 ago 2026, 20:08 UTC

Wolfe Research initiated coverage on Harmony Biosciences with an Outperform rating and a $60 price target, contributing to higher shares during Wednesday's session.

25 ago 2026, 19:26 UTC

Shares of Harmony Biosciences Holdings Inc. are modestly higher, trading within a narrow range amid routine performance during Tuesday's session.

24 ago 2026, 21:01 UTC

Harmony Biosciences Holdings Inc is trading higher in after-market hours, reflecting a broader rebound in the bond market as Treasury yields decline.

21 ago 2026, 22:31 UTC

Harmony Biosciences Holdings Inc. is trading higher in after-market hours, reaching the upper end of its one-month range and above the 20-day moving average.

20 ago 2026, 23:31 UTC

Harmony Biosciences Holdings Inc shares are higher in after-market trading, supported by strong momentum above the 20-day moving average and within its one-month range.

19 ago 2026, 19:56 UTC

Harmony Biosciences Holdings Inc. is trading higher, reaching a session high and remaining above its 20-day moving average during Wednesday's session.

14 ago 2026, 19:46 UTC

Harmony Biosciences shares are lower as the Pharmaceuticals sub-sector declines. The stock remains above its 20-day moving average, indicating some underlying strength.

13 ago 2026, 22:51 UTC

Harmony Biosciences shares are rising in after-market trading, supported by favorable macroeconomic indicators and a broader trend in major averages closing higher.

11 ago 2026, 19:21 UTC

Harmony Biosciences Holdings Inc. is trading higher today, continuing its upward trajectory since Monday's close amid broader market trends and rising oil prices.

10 ago 2026, 19:46 UTC

Harmony Biosciences Holdings Inc is trading higher, continuing its upward trend since Friday. The stock remains above its 20-day moving average.

7 ago 2026, 20:06 UTC

Shares of Harmony Biosciences Holdings Inc. are lower amid broader market declines and decreasing Treasury yields following recent economic data.

6 ago 2026, 23:51 UTC

Harmony Biosciences Holdings Inc shares declined during after-market hours, struggling to maintain earlier gains amid a lack of specific news to explain the movement.

5 ago 2026, 20:03 UTC

Harmony Biosciences shares are lower despite new Phase 1 data on BP-205. Truist maintains a Hold rating and raises the price target to $34.

4 ago 2026, 20:04 UTC

Harmony Biosciences reported strong Q2 earnings of $75.43 million and reaffirmed 2026 revenue guidance, with shares trading sharply higher during the session.